Skip to Content
Contact DCTD
Show menu
Search this site
Last Updated: 12/21/2023

DCTD’s Translational Research Program (TRP) Announces Fiscal Year 2023 SPORE Grantees

Chart showsing SPORE Translational Research

The TRP recently announced its successfully competed FY2023 Specialized Programs of Research Excellence (SPORE) grantees.

The SPORE program uses the P50 and U54 grant funding mechanisms to promote collaborative, interdisciplinary, translational cancer multi-project research. SPOREs are primarily focused on organ site disease, but also on themes that cut across organ sites.

There are now 60 funded SPOREs located at academic centers in 22 states. See information about all SPOREs by organ site and by state.

FY 2023 SPORE Grantees

Principal Investigator Institution Cancer Type
Mitchell Burger University of California, San Francisco Brain*
Maciej S. Lesniak Northwestern University Brain*
Loic Le Marchand; Jeffrey Berenberg University of Hawai`i Cancer Health Disparities
David Mutch; Doris Benbrook; Kimberly Leslie Washington University, St. Louis Endometrial
Ronald Bukanovich; Robert Edwards University of Pittsburgh Ovarian
Anil Sood; Robert Bast University of Texas MD Anderson Cancer Center Ovarian*
William Hawkins; David DeNardo Washington University St. Louis Pancreatic
Himisha Beltran; Steven Balk Dana-Farber Cancer Institute Prostate
David Jarrad; Douglas McNeel University of Wisconsin, Madison Prostate
Peter Nelson Fred Hutchinson Cancer Center Prostate*
Theodore Lawrence; Meredith Morgan University of Michigan, Ann Arbor Radiosensitization
Marcus Bosenberg; Harriet Kluger Yale University Skin*

*Grant Renewal

Goals of the SPORE Program

  • Translating novel scientific discoveries from the laboratory and/or population studies to the clinic for testing in humans with cancer or at risk for cancer
  • Determining the biological basis for clinical observations
  • Using specimens from clinical studies to determine correlations between biomarkers and outcomes in patients
  • Promoting collaborations between SPOREs, Cancer Centers, other NCI/NIH funded mechanisms and programs, and outside organizations
  • Promoting pilot projects and career enhancement of researchers new to translational research
  • Supporting research in high incidence and rare cancers
  • Encouraging communication with advocates and advocate organizations to obtain advice from the patient perspective

Contact TRP staff for more information on the SPORE program.